Clinical expertise with blood vessel administration of antioxidant

http://www.theelixirclinic.com

Background

• Ascorbic acid (vitamin C, ascorbate) could be a key water soluble inhibitor that, once administered in doses well on top of its suggested dietary allowance, could have preventative and therapeutic worth against variety of pathologies

Methods

• Medical records of patients with cancer treated with IVC at the Riordan Clinic were retrospectively reviewed

Results

• The results of the analysis can be summarized as follows

• IVC produces peak plasma ascorbate concentrations on the order of 10 millimolars with lower peak plasma concentrations obtained in cancer patients as compared to healthy subjects

• Cancer patients WHO square measure deficient in vitamin C before medical aid tend to attain lower plasma levels post infusion

Conclusions

• The data indicates that, whereas probably therapeutic plasma ascorbate concentrations is achieved with IVC, levels earned can vary supported tumour burden and degree of inflammation (among alternative factors)

• Find out more at US National Library of Medicine-National Institute of Health